Company History

  • 2022


  • 2021

    Reaching Even Higher Heights

    • With the launch of Nephron Nitrile, a glove manufacturing venture, Nephron begins a $100 million construction project, adding a new 400,000 square-foot facility to its campus of existing facilities and hiring 250 new workers in the process
    • Continued combating the scourge of the COVID-19 pandemic by producing testing chemicals known as reagents, as well as the test kits themselves
    • Partnered with Dominion Energy to open the Nephron Clinical Lab–a way to support Midlands-area residents with fast, reliable COVID-19 vaccination and testing services
    • Developed a new wing of existing Nephron facilities where manufacturers can focus on the creation of life-saving antibiotics and chemotherapy drugs
    • Announced a new syringe and equipment manufacturing venture, Inject EZ
    • Partnered with the ISPE Foundation to launch a new internship program, which aims to diversify Nephron’s ever-growing employee base
  • 2020

    Progress in a Pandemic

    • Nephron steps up to respond to COVID-19, seeking FDA approval to ramp up production
    • Opened a CLIA-certified Diagnostics Lab and began COVID-19 testing for employees, families and businesses in the Midlands and across South Carolina
    • Launched production of FDA approved hand sanitizer
    • Broke ground on a historic $215M expansion, including a vaccine production facility
    • Announced plans for a Kennedy Innovation Complex
    • Received FDA approval of an Abbreviated New Drug Application (ANDA) for two new products – 0.9% Sodium Chloride IV Bags, and Ketorolac Tromethamine Injection Vials
  • 2019


    • Opened in-house pharmacy for employees and their families
    • Launched an educator program that employs over 860 local teachers
    • Reached a total of 2000+ FTE and PTE employees
    • Added 75,000 square feet of clean room manufacturing space
    • Installed 4 new sterile BFS lines
  • 2018


    • Released new opioid free alternatives
    • Established free overnight delivery via UPS
    • Reached a total of 900+ employees
    • Launched a $12.5 million expansion
  • 2017

    Nephron is nationwide

    • Nephron 503B Outsourcing Facility officially launched
    • Became licensed in all 50 states
  • 2016

    Portable relief

    • Budesonide 0.25mg and 0.5mg received ANDA approval
    • National launch of the Pocket Neb
  • 2015

    We're approved

    • After 16 long months, Nephron finally receives full FDA approval
  • 2014

    Nephron moves to South Carolina

    • Nephron headquarters relocated from Orlando, FL to West Columbia, SC
    • Nephron was certified a woman-owned and woman-controlled business by NWBOC (National Women Business Owners Corporation)
  • 2013

    Efficiency through automation

    • The fabrication of the new palletizing systems for the lines at Nephron’s South Carolina facility completed
  • 2012

    Relief, now OTC

    • Sodium Chloride (hypertonic saline) 3% and 7% launched
    • Nephron SC breaks ground
    • Launch of our first OTC Medication Asthmanefrin
  • 2011

    A new economic driver for the Midlands

    • Nephron announced that the company would locate its new operations in Lexington County.
    • The $313 million investment is expected to generate 707 new jobs.
  • 2010

    Expanding our reach

    • Albuterol 0.021% Inhalation Solution ANDA approved
    • Nephron expands distribution facilities with the purchase of a warehouse in Phoenix, AZ
    • Murray, KY warehouse expanded to 150,000 sq. ft.
  • 2009

    Fighting for a level playing field

    • Bill Kennedy hearing before the US House of Representatives on H.R. 1706: Protecting Consumer Access to Generic Drugs Act of 2009
  • 2008

    A year of continued growth

    • Manufacturing Facility Expansion: Construction of an additional formulation weigh suite and filling suite
    • Addition of Rommelag BFS Machines to increase capacity by 18 million vials per month
  • 2007

    Improving efficiency and speed

    • Ipratropium Bromide 0.5mg/ Albuterol Sulfate 3mg Inhalation Solution (DuoDose) ANDA approved
    • Addition of a High Speed Single Vial Packaging Line – 35,000 vials per hour
    • Advanced Processes and Quality Controls
  • 2006

    Keeping up with demand

    • Nephron acquires its first pieces of Bosch high-speed packaging machinery
  • 2005

    Automation promotes accuracy

    • Launched the Electronic Fill Weights – EBR Manager
  • 2004

    A breath of fresh air

    • Albuterol 0.042% Inhalation Solution ANDA approved
  • 2003

    Amplifying production

    • Addition of 4 new Blow-Fill-Seal machines increased capacity to 58 million vials per month
  • 2002

    Getting the word out

    • Lou Kennedy comes on board and begins to build marketing sales force
  • 2001

    Swift growth

    • Albuterol 0.5% Inhalation Solution ANDA approved
    • Ipratropium Bromide 0.02% Inhalation Solution ANDA approved
    • Expansion to 76,000 sq.ft.
    • Addition of single vial, bar coded packaging
  • 2000

    Alleviating respiratory discomfort

    • S2 Racepinephrine Inhalation Solution launched
  • 1999

    Helping patients breathe easy

    • Applied for Albuterol 0.5% Inhalation Solution ANDA
  • 1998

    Outgrowing our space

    • Nephron expanded operations to 56,000 sq. ft.
  • 1997

    Our first product approved

    • Albuterol 0.083% Inhalation Solution ANDA approved